HPV Vaccination: School Vaccination Programme Cuts Risk
Find out how South Africa’s HPV vaccination drive protects teenagers and reduces the incidence of high-risk HPV strains linked to cancer.
Lenacapavir HIV Prevention Injection to Reach Too Few
South Africa’s first consignment of lenacapavir, a six-monthly HIV prevention injection for high-risk HIV-negative people, will cover fewer than a quarter of the target population. Deliveries are underway and will continue through April. Rollout will begin immediately after delivery, with an initial two-year implementation plan…. Membership Required You must be a member to access this...
African Genome Diversity: Wits-Led AGenDA Adds 1,000 Genomes
The African Genome Diversity effort led by Wits adds 1,000+ genomes, improving AI models and precision medicine for African populations.
Wits Health Research Funding Boost Targets Immediate Gaps
Wits Health Research Funding receives a R7m boost from the Oppenheimer Memorial Trust to support those affected by US funding cuts.
Microneedle Eyedrop Delivery System an alternative to eyedrops
Find out how a microneedle eyedrop delivery system offers a groundbreaking alternative to traditional eye drops.
Haemophilia Gene Therapy Offers New Hope
Learn how haemophilia gene therapy offers new hope for patients, thanks to breakthroughs led by South African researcher Johnny Mahlangu.
SA Scientists Pioneer Nanotech Therapy for Lethal Melanoma
Wits University researchers are tackling melanoma with innovative nanotechnology for effective skin cancer therapy.